Navigation Links
Steve Davis Joins Infectious Disease Research Institute (IDRI) as Interim CEO
Date:5/27/2008

SEATTLE, May 27 /PRNewswire/ -- The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research institute, is very pleased to announce that Steve Davis has joined its team as Interim CEO, to assist the organization in its strategic development as a non-profit, product-oriented biotech innovator in global health.

"Steve will be an incredible asset to IDRI," indicated Steve Reed, IDRI's Founder and Head of Research & Development. "He can help take IDRI to the next level and greatly expand our presence in Seattle and the world as we continue to develop great diagnostics and products to save lives around the world."

Steve Davis comes to IDRI in the institute's fifteenth year and brings with him an impressive and diverse career track. Davis has studied Chinese language and law, has served as an advocate in the fields of international refugee and human rights, and has long-held experience in the field of intellectual property.

Most recently, as former CEO of Corbis Corporation, Davis led the small startup company founded in 1989 by Bill Gates to become a leader in the industry of photography, art, and footage rights; today Corbis has approximately 1,000 employees and serves over 50 countries worldwide. Additionally, Davis sits on numerous corporate boards, both profit and non-profit, including the Program for Appropriate Technology in Health (PATH), the Fred Hutchinson Cancer Research Center, The Seattle Foundation, Global Partnerships, Intrepid Learning Solutions, Crucell, Inc., and PlanetOut, Inc. In addition, he currently consults on strategic management issues for several organizations and is a lecturer at the University of Washington's School of Law. He holds degrees from Princeton, University of Washington, and Columbia Law School, and attended certificate programs at Stanford University and Beijing University.

IDRI's board of directors is convinced that Davis' leadership skills and innovative thinking will advance the institute's goals.

Davis plans to help IDRI increase its presence in the biotech and public health communities, as well as enhance IDRI's strategy and organization. "IDRI is an increasingly important player in the global health and research community," Davis says. "Its non-profit biotech model is different from other more well-known scientific research organizations that focus on bench science.

IDRI's goal to create vaccines, therapeutics, and diagnostics for diseases that affect the world's poorest people is powerful. The team here has previously delivered in a number of areas in infectious diseases in the past, and many scientists here have experience in industry. IDRI is clearly an asset for the world of neglected diseases."

About IDRI

IDRI is a non-profit organization committed to developing technologies to treat "neglected" diseases that place a significant burden on those living in the developing world. IDRI achieves its mission by working closely with industry, universities, and hospitals in developed and developing countries, government and private funding agencies, and the World Health Organization. For more information, go to http://www.idri.org.


'/>"/>
SOURCE Infectious Disease Research Institute
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cambrex Appoints Steven M. Klosk as President and CEO
2. Ash Stevens Inc. Named One of Michigan 50 Companies to Watch
3. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
4. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
5. Mylan Announces Appointment of Steven G. Zylstra as Vice President of Global Corporate Communication and Public Relations
6. Thoratec Announces Appointment of Steven H. Collis to Board of Directors
7. Dr. Dinesh Verma to be honored with Presidents Leadership Award at Edwin A. Stevens Society Gala
8. The USC Stevens Institute for Innovation Opens Shop on USC Health Sciences Campus
9. Stevens researchers provide new information about mass spectrometry
10. The USC Stevens Institute for Innovation Opens Shop on US Health Sciences Campus
11. Stevens to host Nanoscience/Nanotechnology & Corrosion symposium, Nov. 13
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... April 27, 2016 , ... PathSensors, Inc., ... Advisory Board. Dr. Lamka will assist PathSensors in expanding the use of the ... deploys the CANARY® test platform for the detection of harmful pathogens, including a ...
(Date:4/27/2016)... April 27, 2016 MedDay, a biotechnology ... announces the appointment of Catherine Moukheibir as Chairman of its ... Chairman, Jean Jacques Garaud , who contributed to the ... effective immediately. Catherine started her career in strategy ... and London .  She held C-Suite level ...
(Date:4/26/2016)... CAMBRIDGE, Mass. (PRWEB) , ... April 26, 2016 , ... ... Herr has been selected as one of three finalists for the European Inventor ... the EPO’s annual innovation prize will be announced at a ceremony in Lisbon on ...
(Date:4/26/2016)... ... April 26, 2016 , ... BioFactura, Inc ., a ... round of financing. Healthy investor interest drove significant oversubscription of the original $1.5M ... known as biosimilars, to the advanced preclinical stages. , Chief Executive Officer and President, ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):